Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization

John H. Chiu, Eric J. Topol, Patrick L. Whitlow, Amy P. Hsu, E. Murat Tuzcu, Irving Franco, David J. Moliterno

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

The association between peripheral vascular disease and outcomes after percutaneous coronary intervention was examined in the Do Tirofiban and Reopro Give Similar Efficacy Outcome Trial (TARGET). After adjustments in a multivariate model, a history of peripheral vascular disease was found to be associated with a two- to threefold increase in mortality at 1 year after coronary stent placement.

Original languageEnglish
Pages (from-to)582-583
Number of pages2
JournalAmerican Journal of Cardiology
Volume92
Issue number5
DOIs
StatePublished - Aug 22 2003

Bibliographical note

Funding Information:
TARGET was supported by Merck and Co., Inc., West Point, Pennsylvania.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization'. Together they form a unique fingerprint.

Cite this